Geisser P, Müller A
Arzneimittelforschung. 1987 Jan;37(1A):100-4.
Pharmacokinetic measurements of ferrous sulphate and ferric hydroxide-polymaltose complex on anaemic and non-anaemic rats have shown different postabsorption serum iron levels, invasion and elimination constants and distribution volumes for the two preparations. But nevertheless the absorption and utilization ratios of iron from both preparations are equal. It is therefore not justified to calculate utilization ratios for chemically different iron preparations on the basis of postabsorption serum iron measurements. Similar pharmacokinetic differences of these two iron preparations could also be found in clinical trials, which means that different serum iron increase results in an equal utilization ratio for both preparations. It is clear that ferrous sulphate and ferric hydroxide-polymaltose complex must have a different absorption mechanism. The postulated absorption mechanism is in agreement with all the facts known today and does explain the pharmacokinetic difference between the investigated preparations.
对贫血和非贫血大鼠进行硫酸亚铁和氢氧化铁-聚麦芽糖复合物的药代动力学测量结果显示,两种制剂吸收后的血清铁水平、侵入和消除常数以及分布容积均有所不同。但尽管如此,两种制剂中铁的吸收和利用率却是相等的。因此,根据吸收后的血清铁测量值来计算化学性质不同的铁制剂的利用率是不合理的。在临床试验中也能发现这两种铁制剂存在类似的药代动力学差异,这意味着不同的血清铁升高结果导致两种制剂的利用率相等。显然,硫酸亚铁和氢氧化铁-聚麦芽糖复合物必定具有不同的吸收机制。所假定的吸收机制与目前已知的所有事实相符,并且确实解释了所研究制剂之间的药代动力学差异。